Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease.

eLife

Si J, Li J, Yu C, Guo Y, Bian Z, Millwood I, Yang L, Walters R, Chen Y, Du H, Yin L, Chen J, Chen J, Chen Z, Li L, Liang L, Lv J.
PMID: 33558007
Elife. 2021 Feb 09;10. doi: 10.7554/eLife.60999.

Adherence to healthy lifestyles is associated with reduced risk of coronary heart disease (CHD), but uncertainty persists about the underlying lipid pathway. In a case-control study of 4681 participants nested in the prospective China Kadoorie Biobank, 61 lipidomic markers...

Cite
Si J, Li J, Yu C, et al. Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease. Elife. 2021;10doi: 10.7554/eLife.60999.
Si, J., Li, J., Yu, C., Guo, Y., Bian, Z., Millwood, I., Yang, L., Walters, R., Chen, Y., Du, H., Yin, L., Chen, J., Chen, J., Chen, Z., Li, L., Liang, L., & Lv, J. (2021). Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease. eLife, 10. https://doi.org/10.7554/eLife.60999
Si, Jiahui, et al. "Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.60999
Si J, Li J, Yu C, Guo Y, Bian Z, Millwood I, Yang L, Walters R, Chen Y, Du H, Yin L, Chen J, Chen J, Chen Z, Li L, Liang L, Lv J. Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease. Elife. 2021 Feb 09;10. doi: 10.7554/eLife.60999. PMID: 33558007; PMCID: PMC7872516.
Copy Download .nbib Format: NLM
Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey.

International journal of hypertension

Tapela NM, Clifton L, Tshisimogo G, Gaborone M, Madidimalo T, Letsatsi V, Masupe T, Mosepele M, Makhema J, Lockman S, Hunter DJ.
PMID: 32550019
Int J Hypertens. 2020 May 31;2020:8082341. doi: 10.1155/2020/8082341. eCollection 2020.

INTRODUCTION: Hypertension is a leading risk factor for cardiovascular mortality and an emerging public health concern in sub-Saharan Africa. Few studies have examined performance on the management of hypertension in this region, where the context may be distinct from...

Cite
Tapela NM, Clifton L, Tshisimogo G, et al. Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey. Int J Hypertens. 2020;2020:8082341doi: 10.1155/2020/8082341.
Tapela, N. M., Clifton, L., Tshisimogo, G., Gaborone, M., Madidimalo, T., Letsatsi, V., Masupe, T., Mosepele, M., Makhema, J., Lockman, S., & Hunter, D. J. (2020). Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey. International journal of hypertension, 20208082341. https://doi.org/10.1155/2020/8082341
Tapela, Neo M, et al. "Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey." International journal of hypertension vol. 2020 (2020): 8082341. doi: https://doi.org/10.1155/2020/8082341
Tapela NM, Clifton L, Tshisimogo G, Gaborone M, Madidimalo T, Letsatsi V, Masupe T, Mosepele M, Makhema J, Lockman S, Hunter DJ. Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey. Int J Hypertens. 2020 May 31;2020:8082341. doi: 10.1155/2020/8082341. eCollection 2020. PMID: 32550019; PMCID: PMC7281842.
Copy Download .nbib Format: NLM
Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases.

JAMA cardiology

Pang Y, Kartsonaki C, Lv J, Fairhurst-Hunter Z, Millwood IY, Yu C, Guo Y, Chen Y, Bian Z, Yang L, Chen J, Clarke R, Walters RG, Holmes MV, Li L, Chen Z.
PMID: 33263724
JAMA Cardiol. 2021 Mar 01;6(3):276-286. doi: 10.1001/jamacardio.2020.6041.

IMPORTANCE: Obesity is associated with a higher risk of cardiovascular disease (CVD), but little is known about the role that circulating protein biomarkers play in this association.OBJECTIVE: To examine the observational and genetic associations of adiposity with circulating protein...

Cite
Pang Y, Kartsonaki C, Lv J, et al. Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases. JAMA Cardiol. 2021;6(3):276-286doi: 10.1001/jamacardio.2020.6041.
Pang, Y., Kartsonaki, C., Lv, J., Fairhurst-Hunter, Z., Millwood, I. Y., Yu, C., Guo, Y., Chen, Y., Bian, Z., Yang, L., Chen, J., Clarke, R., Walters, R. G., Holmes, M. V., Li, L., & Chen, Z. (2021). Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases. JAMA cardiology, 6(3), 276-286. https://doi.org/10.1001/jamacardio.2020.6041
Pang, Yuanjie, et al. "Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases." JAMA cardiology vol. 6,3 (2021): 276-286. doi: https://doi.org/10.1001/jamacardio.2020.6041
Pang Y, Kartsonaki C, Lv J, Fairhurst-Hunter Z, Millwood IY, Yu C, Guo Y, Chen Y, Bian Z, Yang L, Chen J, Clarke R, Walters RG, Holmes MV, Li L, Chen Z. Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases. JAMA Cardiol. 2021 Mar 01;6(3):276-286. doi: 10.1001/jamacardio.2020.6041. PMID: 33263724; PMCID: PMC7711564.
Copy Download .nbib Format: NLM
Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry.

Stroke and vascular neurology

Qin H, Chen Y, Liu G, Turnbull I, Zhang R, Li Z, Wang Y, Liu L, Zhao X, Chen Z, Wang Y.
PMID: 32571805
Stroke Vasc Neurol. 2021 Mar;6(1):1-9. doi: 10.1136/svn-2020-000340. Epub 2020 Jun 22.

BACKGROUND AND PURPOSE: There is limited nationwide evidence about the standard management characteristics of stroke types and prognosis in China. This study aimed to assess clinical characteristics, in-hospital and after-discharge management characteristics and prognosis for stroke types in China.METHODS:...

Cite
Qin H, Chen Y, Liu G, et al. Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry. Stroke Vasc Neurol. 2020;6(1):1-9doi: 10.1136/svn-2020-000340.
Qin, H., Chen, Y., Liu, G., Turnbull, I., Zhang, R., Li, Z., Wang, Y., Liu, L., Zhao, X., Chen, Z., & Wang, Y. (2021). Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry. Stroke and vascular neurology, 6(1), 1-9. https://doi.org/10.1136/svn-2020-000340
Qin, Haiqiang, et al. "Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry." Stroke and vascular neurology vol. 6,1 (2021): 1-9. doi: https://doi.org/10.1136/svn-2020-000340
Qin H, Chen Y, Liu G, Turnbull I, Zhang R, Li Z, Wang Y, Liu L, Zhao X, Chen Z, Wang Y. Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry. Stroke Vasc Neurol. 2021 Mar;6(1):1-9. doi: 10.1136/svn-2020-000340. Epub 2020 Jun 22. PMID: 32571805; PMCID: PMC8005905.
Copy Download .nbib Format: NLM
Group Testing for SARS-CoV-2: Forward to the Past?.

PharmacoEconomics - open

Pouwels KB, Roope LSJ, Barnett A, Hunter DJ, Nolan TM, Clarke PM.
PMID: 32347512
Pharmacoecon Open. 2020 Jun;4(2):207-210. doi: 10.1007/s41669-020-00217-8.

No abstract available.

Cite
Pouwels KB, Roope LSJ, Barnett A, et al. Group Testing for SARS-CoV-2: Forward to the Past?. Pharmacoecon Open. 2020;4(2):207-210doi: 10.1007/s41669-020-00217-8.
Pouwels, K. B., Roope, L. S. J., Barnett, A., Hunter, D. J., Nolan, T. M., & Clarke, P. M. (2020). Group Testing for SARS-CoV-2: Forward to the Past?. PharmacoEconomics - open, 4(2), 207-210. https://doi.org/10.1007/s41669-020-00217-8
Pouwels, Koen B, et al. "Group Testing for SARS-CoV-2: Forward to the Past?." PharmacoEconomics - open vol. 4,2 (2020): 207-210. doi: https://doi.org/10.1007/s41669-020-00217-8
Pouwels KB, Roope LSJ, Barnett A, Hunter DJ, Nolan TM, Clarke PM. Group Testing for SARS-CoV-2: Forward to the Past?. Pharmacoecon Open. 2020 Jun;4(2):207-210. doi: 10.1007/s41669-020-00217-8. PMID: 32347512; PMCID: PMC7187661.
Copy Download .nbib Format: NLM
Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases.

JAMA cardiology

Pang Y, Kartsonaki C, Lv J, Fairhurst-Hunter Z, Millwood IY, Yu C, Guo Y, Chen Y, Bian Z, Yang L, Chen J, Clarke R, Walters RG, Holmes MV, Li L, Chen Z.
PMID: 33263724
JAMA Cardiol. 2021 Mar 01;6(3):276-286. doi: 10.1001/jamacardio.2020.6041.

IMPORTANCE: Obesity is associated with a higher risk of cardiovascular disease (CVD), but little is known about the role that circulating protein biomarkers play in this association.OBJECTIVE: To examine the observational and genetic associations of adiposity with circulating protein...

Cite
Pang Y, Kartsonaki C, Lv J, et al. Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases. JAMA Cardiol. 2021;6(3):276-286doi: 10.1001/jamacardio.2020.6041.
Pang, Y., Kartsonaki, C., Lv, J., Fairhurst-Hunter, Z., Millwood, I. Y., Yu, C., Guo, Y., Chen, Y., Bian, Z., Yang, L., Chen, J., Clarke, R., Walters, R. G., Holmes, M. V., Li, L., & Chen, Z. (2021). Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases. JAMA cardiology, 6(3), 276-286. https://doi.org/10.1001/jamacardio.2020.6041
Pang, Yuanjie, et al. "Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases." JAMA cardiology vol. 6,3 (2021): 276-286. doi: https://doi.org/10.1001/jamacardio.2020.6041
Pang Y, Kartsonaki C, Lv J, Fairhurst-Hunter Z, Millwood IY, Yu C, Guo Y, Chen Y, Bian Z, Yang L, Chen J, Clarke R, Walters RG, Holmes MV, Li L, Chen Z. Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases. JAMA Cardiol. 2021 Mar 01;6(3):276-286. doi: 10.1001/jamacardio.2020.6041. PMID: 33263724; PMCID: PMC7711564.
Copy Download .nbib Format: NLM
Systemic inflammation is associated with incident stroke and heart disease in East Asians.

Scientific reports

Karim MA, Kartsonaki C, Bennett DA, Millwood IY, Hill MR, Avery D, Bian Z, Du H, Guo Y, Qian Y, Qu C, Turnbull I, Schmidt-Valle D, Wang C, Yu C, Lv J, Chen J, Clarke R, Li L, Chen Z, Holmes MV, Walters RG.
PMID: 32221345
Sci Rep. 2020 Mar 27;10(1):5605. doi: 10.1038/s41598-020-62391-3.

Systemic inflammation, reflected by increased plasma concentrations of C-reactive protein (CRP) and fibrinogen, is associated with increased risk of coronary heart disease, but its relevance for stroke types remains unclear. Moreover, evidence is limited in non-European populations. We investigated...

Cite
Karim MA, Kartsonaki C, Bennett DA, et al. Systemic inflammation is associated with incident stroke and heart disease in East Asians. Sci Rep. 2020;10(1):5605doi: 10.1038/s41598-020-62391-3.
Karim, M. A., Kartsonaki, C., Bennett, D. A., Millwood, I. Y., Hill, M. R., Avery, D., Bian, Z., Du, H., Guo, Y., Qian, Y., Qu, C., Turnbull, I., Schmidt-Valle, D., Wang, C., Yu, C., Lv, J., Chen, J., Clarke, R., Li, L., Chen, Z., Holmes, M. V., Walters, R. G. (2020). Systemic inflammation is associated with incident stroke and heart disease in East Asians. Scientific reports, 10(1), 5605. https://doi.org/10.1038/s41598-020-62391-3
Karim, Mohd A, et al. "Systemic inflammation is associated with incident stroke and heart disease in East Asians." Scientific reports vol. 10,1 (2020): 5605. doi: https://doi.org/10.1038/s41598-020-62391-3
Karim MA, Kartsonaki C, Bennett DA, Millwood IY, Hill MR, Avery D, Bian Z, Du H, Guo Y, Qian Y, Qu C, Turnbull I, Schmidt-Valle D, Wang C, Yu C, Lv J, Chen J, Clarke R, Li L, Chen Z, Holmes MV, Walters RG. Systemic inflammation is associated with incident stroke and heart disease in East Asians. Sci Rep. 2020 Mar 27;10(1):5605. doi: 10.1038/s41598-020-62391-3. PMID: 32221345; PMCID: PMC7101367.
Copy Download .nbib Format: NLM
Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic.

Royal Society open science

Peto J, Carpenter J, Smith GD, Duffy S, Houlston R, Hunter DJ, McPherson K, Pearce N, Romer P, Sasieni P, Turnbull C.
PMID: 32742705
R Soc Open Sci. 2020 Jun 24;7(6):200915. doi: 10.1098/rsos.200915. eCollection 2020 Jun.

The COVID-19 epidemic can probably be ended and normal life restored, perhaps quite quickly, by weekly SARS-CoV-2 RNA testing together with household quarantine and systematic contact tracing. Isolated outbreaks could then be contained by contact tracing, supplemented if necessary...

Cite
Peto J, Carpenter J, Smith GD, et al. Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic. R Soc Open Sci. 2020;7(6):200915doi: 10.1098/rsos.200915.
Peto, J., Carpenter, J., Smith, G. D., Duffy, S., Houlston, R., Hunter, D. J., McPherson, K., Pearce, N., Romer, P., Sasieni, P., & Turnbull, C. (2020). Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic. Royal Society open science, 7(6), 200915. https://doi.org/10.1098/rsos.200915
Peto, Julian, et al. "Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic." Royal Society open science vol. 7,6 (2020): 200915. doi: https://doi.org/10.1098/rsos.200915
Peto J, Carpenter J, Smith GD, Duffy S, Houlston R, Hunter DJ, McPherson K, Pearce N, Romer P, Sasieni P, Turnbull C. Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic. R Soc Open Sci. 2020 Jun 24;7(6):200915. doi: 10.1098/rsos.200915. eCollection 2020 Jun. PMID: 32742705; PMCID: PMC7353981.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries